NABRIVA THERAPEUTICS PLC

Profile

Company Names

NABRIVA THERAPEUTICS PLC

Addresses

25-28 NORTH WALL QUAY, IFSC, DUBLIN 1, L2 2

Phone Numbers

(610) 816-6640

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

IRELAND

Total Amount Raised:

$21,301,451.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-07-24 
$21,301,451.00 
$26,901,904.00 
$5,600,453.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AXEL 
 
BOLTE 
DIRECTOR
LUX BIOSCIENCES INC   |  KOLLTAN PHARMACEUTICALS INC   |  PTC THERAPEUTICS, INC.   |  OPHTHOTECH CORP.   |  ALLENA PHARMACEUTICALS, INC.   |  NABRIVA THERAPEUTICS PLC   |  INOZYME PHARMA, INC.
CARRIE 
 
BOURDOW 
DIRECTOR
NABRIVA THERAPEUTICS PLC
COLIN 
 
BROOM 
DIRECTOR
NABRIVA THERAPEUTICS PLC   |  PULMOTECT, INC.
DANIEL 
 
BURGESS 
DIRECTOR
ARSANIS, INC.   |  ATOX BIO INC.   |  NABRIVA THERAPEUTICS PLC   |  QPEX BIOPHARMA, INC.   |  THERINI BIO, INC.   |  ARBUTUS BIOPHARMA CORP
MARK 
 
CORRIGAN 
DIRECTOR
SYNERECA PHARMACEUTICALS, INC.   |  TREMEAU PHARMACEUTICALS, INC.   |  NABRIVA THERAPEUTICS PLC   |  EXACIS BIOTHERAPEUTICS INC.
ROBERT 
 
CROTTY 
EXECUTIVE OFFICER
GTA DEVELOPMENT FUND, LLC   |  NABRIVA THERAPEUTICS PLC   |  5TH KIND, INC
STEVEN 
 
GELONE 
EXECUTIVE OFFICER
NABRIVA THERAPEUTICS PLC
FRANCESCO 
MARIA 
LAVINO 
EXECUTIVE OFFICER
NABRIVA THERAPEUTICS PLC
CHARLES 
A. 
ROWLAND 
DIRECTOR
NABRIVA THERAPEUTICS PLC
JENNIFER 
 
SCHRANZ 
EXECUTIVE OFFICER
NABRIVA THERAPEUTICS PLC   |  OCELOT BIO, INC.
THEODORE 
 
SCHROEDER 
EXECUTIVE OFFICER, DIRECTOR
ONLINE SHEET MUSIC, INC.   |  NABRIVA THERAPEUTICS PLC   |  COLLEGIUM PHARMACEUTICAL, INC
GARY 
 
SENDER 
EXECUTIVE OFFICER
NABRIVA THERAPEUTICS PLC   |  GENNAO BIO, INC.   |  ELUCIDA ONCOLOGY, INC.   |  IBIO, INC.   |  APNIMED, INC.
GEORGE 
H. 
TALBOT 
DIRECTOR
NABRIVA THERAPEUTICS PLC
STEPHEN 
 
WEBSTER 
DIRECTOR
AVISTA CAPITAL PARTNERS II, L.P.   |  AVISTA CAPITAL PARTNERS (OFFSHORE) II, L.P.   |  AVISTA CAPITAL PARTNERS III, L.P.   |  AVISTA CAPITAL PARTNERS (OFFSHORE) III, L.P.   |  NABRIVA THERAPEUTICS PLC   |  NEXTCURE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-07-27
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2018-07-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#